ASO Author Reflections: International Standardization of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Protocols-Malignant Peritoneal Mesothelioma as a Model

Vahan Kepenekian^{1

2}, Olivia Sgarbura³, Frederic Marchal⁴, Laurent Villeneuve^{5

6}, Shigeki Kusamura⁷, Marcello Deraco⁷

Affiliations

¹ Service de Chirurgie Digestive, Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France. vahan.kepenekian@chu-lyon.fr.
² CICLY, Faculté de Médecine Lyon-Sud, Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France. vahan.kepenekian@chu-lyon.fr.
³ Surgical Oncology Department, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France.
⁴ Department of Surgical Oncology, Institut de Cancérologie de Lorraine, Université de Lorraine, Nancy, France.
⁵ CICLY, Faculté de Médecine Lyon-Sud, Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France.
⁶ Service de Recherche et d'Epidémiologie Cliniques, Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, Lyon, France.
⁷ Peritoneal Malignancy Program, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Comment

Vahan Kepenekian et al. Ann Surg Oncol. 2023 Nov.

. 2023 Nov;30(12):7858-7859.

doi: 10.1245/s10434-023-14120-z. Epub 2023 Aug 25.

Vahan Kepenekian^{1

2}, Olivia Sgarbura³, Frederic Marchal⁴, Laurent Villeneuve^{5

6}, Shigeki Kusamura⁷, Marcello Deraco⁷

¹ Service de Chirurgie Digestive, Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France. vahan.kepenekian@chu-lyon.fr.
² CICLY, Faculté de Médecine Lyon-Sud, Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France. vahan.kepenekian@chu-lyon.fr.
³ Surgical Oncology Department, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France.
⁴ Department of Surgical Oncology, Institut de Cancérologie de Lorraine, Université de Lorraine, Nancy, France.
⁵ CICLY, Faculté de Médecine Lyon-Sud, Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France.
⁶ Service de Recherche et d'Epidémiologie Cliniques, Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, Lyon, France.
⁷ Peritoneal Malignancy Program, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

No abstract available

Comment on

The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: Methodology.
Kusamura S, Bhatt A, Hubner M, Villeneuve L, Deraco M, Bakrin N, Van Der Speeten K, Glehen O. Kusamura S, et al. Ann Surg Oncol. 2023 Apr;30(4):2508-2519. doi: 10.1245/s10434-022-12990-3. Epub 2023 Jan 3. Ann Surg Oncol. 2023. PMID: 36595113

1. Sugarbaker PH, Averbach AM, Jacquet P, Stephens AD, Stuart OA. Peritoneal carcinomatosis: principles of management. Canc Treat. 1996;82:415–21. https://doi.org/10.1007/978-1-4613-1247-5_26 . - DOI
1. Kusamura S, Kepenekian V, Villeneuve L, et al. Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol. 2020. https://doi.org/10.1016/j.ejso.2020.02.011 . - DOI - PubMed
1. Bartlett DL, Buell JF, Libutti SK, et al. A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis. Cancer. 1998;83(6):1251–61. - DOI - PubMed
1. Kepenekian V, Sgarbura O, Marchal F, Villeneuve L, Kusamura S, Deraco M. 2022 PSOGI consensus on HIPEC regimens for peritoneal malignancies: diffuse malignant peritoneal mesothelioma. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-13973-8 . - DOI - PubMed - PMC
1. Kusamura S, Bhatt A, Hubner M, et al. The 2022 PSOGI international consensus on HIPEC regimens for peritoneal malignancies: methodology. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-022-12990-3 . - DOI - PubMed